Literature DB >> 12657313

The conserved structure of snake venom toxins confers extensive immunological cross-reactivity to toxin-specific antibody.

R A Harrison1, W Wüster, R D G Theakston.   

Abstract

We have demonstrated previously that antisera from mice immunised with DNA encoding the carboxy-terminal domain (JD9) of a potent haemorrhagic metalloproteinase, jararhagin, neutralised over 70% of the haemorrhagic activity of the whole Bothrops jararaca venom. Here, we demonstrate that the JD9-specific antibody possesses extensive immunological reactivity to venom components in snakes of distinct species and genera. The polyspecific immunological reactivity of the antibody showed a correlation with amino acid sequence identity and with predicted antigenic domains of JD9-analogues in venoms of snakes with closest phylogenetic links to B. jararaca. This study further promotes the potential of DNA immunisation to generate toxin-specific antibodies with polyspecific cover. An analysis of the reactivity of the JD9-specific antisera to B. atrox complex venoms that exhibited intraspecific variation in the venom proteome revealed, however, that the toxin-specific approach to antivenom development requires a more in-depth knowledge of the target molecules than is required for conventional antivenoms.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12657313     DOI: 10.1016/s0041-0101(02)00360-4

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  7 in total

1.  Bioinformatics and multiepitope DNA immunization to design rational snake antivenom.

Authors:  Simon C Wagstaff; Gavin D Laing; R David G Theakston; Christina Papaspyridis; Robert A Harrison
Journal:  PLoS Med       Date:  2006-06       Impact factor: 11.069

2.  Pharmacokinetics of Naja sumatrana (equatorial spitting cobra) venom and its major toxins in experimentally envenomed rabbits.

Authors:  Michelle Khai Khun Yap; Nget Hong Tan; Si Mui Sim; Shin Yee Fung; Choo Hock Tan
Journal:  PLoS Negl Trop Dis       Date:  2014-06-05

3.  Effective equine immunization protocol for production of potent poly-specific antisera against Calloselasma rhodostoma, Cryptelytrops albolabris and Daboia siamensis.

Authors:  Sompong Sapsutthipas; Poh Kuan Leong; Surasak Akesowan; Ronachai Pratanaphon; Nget Hong Tan; Kavi Ratanabanangkoon
Journal:  PLoS Negl Trop Dis       Date:  2015-03-16

4.  A pan-specific antiserum produced by a novel immunization strategy shows a high spectrum of neutralization against neurotoxic snake venoms.

Authors:  Kavi Ratanabanangkoon; Kae Yi Tan; Kritsada Pruksaphon; Chaiya Klinpayom; José María Gutiérrez; Naeem H Quraishi; Choo Hock Tan
Journal:  Sci Rep       Date:  2020-07-09       Impact factor: 4.379

5.  The paraspecific neutralisation of snake venom induced coagulopathy by antivenoms.

Authors:  Stuart Ainsworth; Julien Slagboom; Nessrin Alomran; Davinia Pla; Yasir Alhamdi; Sarah I King; Fiona M S Bolton; José María Gutiérrez; Freek J Vonk; Cheng-Hock Toh; Juan J Calvete; Jeroen Kool; Robert A Harrison; Nicholas R Casewell
Journal:  Commun Biol       Date:  2018-04-19

Review 6.  Snake venom L-amino acid oxidases: trends in pharmacology and biochemistry.

Authors:  Luiz Fernando M Izidoro; Juliana C Sobrinho; Mirian M Mendes; Tássia R Costa; Amy N Grabner; Veridiana M Rodrigues; Saulo L da Silva; Fernando B Zanchi; Juliana P Zuliani; Carla F C Fernandes; Leonardo A Calderon; Rodrigo G Stábeli; Andreimar M Soares
Journal:  Biomed Res Int       Date:  2014-03-12       Impact factor: 3.411

7.  Interaction between TNF and BmooMP-Alpha-I, a Zinc Metalloprotease Derived from Bothrops moojeni Snake Venom, Promotes Direct Proteolysis of This Cytokine: Molecular Modeling and Docking at a Glance.

Authors:  Maraisa Cristina Silva; Tamires Lopes Silva; Murilo Vieira Silva; Caroline Martins Mota; Fernanda Maria Santiago; Kelly Cortes Fonseca; Fábio Oliveira; Tiago Wilson Patriarca Mineo; José Roberto Mineo
Journal:  Toxins (Basel)       Date:  2016-07-20       Impact factor: 4.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.